Clinical Outcome of Intravenous Immunoglobulin in the treatment of Guillain Barre Syndrome in a Nepalese Tertiary Centre

Introduction: Intravenous Immunoglobulin is an approved therapy for Guillain Barre Syndrome. Our objective is to understand the management and outcome in Guillain Barre Syndrome patients treated with Immunoglobulin. Materials and Methods: All consecutive patients were retrospectively evaluated in th...

Full description

Bibliographic Details
Main Authors: Rajeev Ojha, Ragesh Karn
Format: Article
Language:English
Published: HEAD Nepal 2019-06-01
Series:Nepalese Medical Journal
Subjects:
Online Access:https://www.nepjol.info/index.php/nmj/article/view/24000